Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Not true, you better do your DD on AMBS.
From Energy Digital website. http://issuu.com/energydigital/docs/energydigital-november2014?e=12457992/9854388
Easier to check the magazine.
How come there are no news (Press Release) about it?
Wow! That is good news!
Thanks!
What is their products Development Pipeline for MyoCell, MyoCell SDF-1, MyoCath and AdipoCell?
The post was from zoomboom: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=91226993
to gerald (AMBS) - Email regarding LymPro Trademark
http://trademarks.justia.com/owners/gw-medical-technologies-llc-1984933/
Hello Gerald,
do you own this trademark?see link or will this be an issue for LymPro
regards.
XXXXX XXXXXX
Gerald Commissiong
That is ours. GW is a predecessor to Provista
Gerald E. Commissiong
President & CEO
Amarantus Bioscience Holdings, Inc
675 Almanor Ave.
Sunnyvale, CA 94085
Email: gerald@amarantus.com
Phone: 408-737-2734 x 102
Sooner the better!
600 Billion, is too high!
I do not think that sold LymPro.
600 million deal?
And the full dataset on 140 patients in mild, moderate and severe Alzheimer's disease subjects expected to be announced in December 2014.
Sounds really good!
JN - Astute Deal Brings In Another Shot On Goal For Amarantus Bio - Wednesday, November 19, 2014
If you don't have anything nice to say, don't say it. I am with CEO 100%
Regenicin Inc. (RGIN) - Agreement with AMBS
Current Report Filing (8-k)
http://ih.advfn.com/p.php?pid=nmona&article=64448131
Dr. Joseph Rubinfeld, who is currently a member of Regenicin's Board of Directors, has agreed to join the Amarantus Board of Directors. He plans to continue his involvement with the advancement of ESS.
Dr. Rubinfeld has been a director since July 2002. He co-founded SuperGen, Inc. in 1991 and has served as its Chief Executive Officer and President and as a director since its inception until December 31, 2003. He resigned as Chairman Emeritus of SuperGen, Inc. on February 8, 2005. Dr. Rubinfeld was also Chief Scientific Officer of SuperGen from 1991 until September 1997. Dr. Rubinfeld was one of the four initial founders of Amgen, Inc. in 1980 and served as a Vice President and its Chief of Operations until 1983. From 1987 until 1990, Dr. Rubinfeld was a Senior Director at Cetus Corporation and from 1968 to 1980, Dr. Rubinfeld was employed at Bristol-Myers Company, International Division in a variety of positions. Dr. Rubinfeld received a B.S. degree in chemistry from C.C.N.Y. and an M.A. and Ph.D. in chemistry from Columbia University.
I hope you good luck!
WindStream Technologies to Exhibit Its MobileMill(TM) and SolarMill(R) Technologies at 2014 New Jersey State League of Municipalities Conference November 17-20, 2014
http://www.marketwatch.com/story/windstream-technologies-to-exhibit-its-mobilemilltm-and-solarmillr-technologies-at-2014-new-jersey-state-league-of-municipalities-conference-november-17-20-2014-2014-11-17
Check the Form 10-Q for WINDSTREAM TECHNOLOGIES, INC. http://biz.yahoo.com/e/141114/wsti10-q.html
14-Nov-2014
Results of Operations for the Three Months Ended September 30, 2014 and 2013:
Three Months Ended
Sept. 30, 2014 Sept. 30, 2013
Sales $ 373,538 $ 47,857
Gross Profit (Loss) $ (311,990 ) $ (10,039 )
Research and Development Expenses $ 91,666 $ 314,071
General and Administrative Expenses $ 867,094 $ 681,996
Operating Expenses $ 958,760 $ 996,067
Other Income (Expense) $ (216,609 ) $ (172,098 )
Net Loss $ (1,487,359 ) $ (1,178,204 )
Now I can see why they are on doing terrible. Hope they will start selling like crazy soon.
Yes I did, big mistake!
I do not trust WSTI, look to me it is a scam. How can it go down 7 cents in one day. Or their business went downhill. Now only .20
I am not happy with this company. :0(
I would to know why the pps going down too fast. This is not good. Let me know what WSTI said about that article. Good Luck!
Could be, I am not sure what is going on. The pps keep going down too fast. No, I never asked anyone at the company. If you are right, it can go down to .0001
I would like to know who is the paying party that is behind the fraud promo. I know that WSTI is a real company.
Check their business on Google Map: https://www.google.ca/maps/@39.0056593,-85.6179998,3a,75y,228.93h,82.14t/data=!3m4!1e1!3m2!1sxqB7NVNb0PoksdrTvUtRXg!2e0!6m1!1e1?hl=en
That is good to know!
I hope we will not have problems with Dominion Capital.
Yes, sounds really good! I hope the transaction will succeed.
Amarantus Bioscience : Reports Third Quarter 2014 Financial Results and Enters Into Strategic Preferred Financing
"The third quarter was marked by the achievement of key milestones on the operational, clinical and regulatory fronts," said Gerald. E. Commissiong, President and CEO of Amarantus. "Throughout the quarter we were preparing in earnest for the first phase of our launch of LymPro diagnostic for Alzheimer's disease anticipated before year end, the start of two Phase 2b studies of Eltoprazine for PD LID and ADHD, and putting MANF into a regulatory framework with the FDA. In addition we worked to strengthen our balance sheet, and are pleased to have the ability to both extend our cash runway and expand our product portfolio with an asset that we believe has tremendous potential."
Commissiong, concluded, "Moving forward, we remain committed to the execution of our strategy, and I am confident we are poised for a transformational 2015. Importantly, I believe this will successfully translate into the opportunity to unlock significant shareholder value in the near and long term."
I am doing my DD and I am getting bad information about CHLO. Sorry, this is a scam!
Again I agree with sante1!
CHLO with OTC Pink - an open marketplace for a broad spectrum of equity securities, with no financial standards or reporting requirements.
OTC Markets require companies to be current in their SEC or other regulatory disclosure to be quoted in the OTCQB marketplace. Companies must also be current in providing disclosure to be quoted in the OTCQX marketplace, though that requirement can be met by providing information in accordance with OTC Link's proprietary Alternative Reporting Standard rather than through filing with the SEC or a banking or insurance regulator.
Companies quoted in the OTC Pink tier are assigned different symbols by OTC Markets, depending on whether they have provided "current" information, "limited" information or "no information." You can find the symbol currently assigned to a stock by OTC Markets and read more about the OTC Market marketplaces at www.otcmarkets.com.
http://www.sec.gov/investor/pubs/microcapstock.htm
WOW! A lot of R/S!
The Greatest Stock Market Loser of All Time
https://www.globalfinancialdata.com/gfdblog/?p=458
I trust the CEO 100%
I agree with sante1